Inactive Instrument

Highlights Intellego Technologies AB

Equities

INT

SE0016075063

Biotechnology & Medical Research

Highlights

02-20	Intellego Technologies AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
02-20	Intellego Technologies reports Q4 numbers amid investigation	RE
01-21	Intellego Technologies Flags Delisting from Nasdaq First North Growth Market	MT
01-16	Intellego Technologies requests to extend investigation over former CEO	RE
01-05	Intellego announces cancellation of Moveomed order	RE
01-03	Intellego Technologies Announces Cancellation of Order from MoveoMed GmbH	CI
12-30	Intellego Technologies says FDA approves QIKcap by HAI Solutions	RE
12-30	Hai Solutions Receives Fda Approval for Qikcap	CI
12-17	Heights Capital Management poses claim on Intellego Technologies	RE
12-10	Intellego appeals asset freeze	RE
11-28	Intellego says Deloitte to submit report of accounting fraud suspicion	RE
11-26	Intellego Technologies dismisses CEO, engages KPMG for investigation	RE
11-21	Intellego Technologies CEO Steps Down over Criminal Probe; Interim CEO Named	MT
11-21	Intellego Has Until December 5 to Respond to Allegations	FW
11-21	Intellego appoints Jacob Laurin as interim CEO	RE
11-18	Intellego Technologies' CEO arrested on suspicion of gross fraud	RE
11-17	Shanghai Zhongyou Medical High Tech Co., Ltd Continues to Purchase Intellego Technologies AB's Standardized UV Doseimeter Products in China	CI
11-11	Intellego Technologies Q3 results, financial targets for 2026-2028	RE
11-10	Intellego Technologies AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
04/10/25	Intellego Technologies AB Announces That Its Subsidiary Yuvio Receives Order Worth EUR 22 Million	CI
02/10/25	Intellego provides additional information on cash position	RE
02/10/25	Intellego Q3 EBIT exceeds SEK 130 mln	RE
15/09/25	Intellego Technologies surpasses SEK 400 mln in EBIT for 2025	RE
27/08/25	Intellego Technologies AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
01/07/25	Intellego Technologies AB Provides Preliminary Earnings Guidance for the Second Quarter of 2025	CI